(Updates share price)Oculus Innovative Sciences ( OCLS) appears to be skirting U.S. drug laws by claiming that its wound-cleansing product containing common diluted bleach has drug-like therapeutic properties. The Petaluma, Calif.-based company sells Microcyn, a liquid- and gel-based antiseptic sold over the counter for $20 a bottle that is used to clean minor skin abrasions and irrigate or dress more serious wounds like leg and diabetic ulcers. The U.S. Food and Drug Administration allows Oculus to market Microcyn as a wound cleaner under the agency's regulation of simple medical devices known as 510(k) approvals. Microcyn is similar to numerous other wound-cleaning products sold commercially for years.
|Oculus refused to verify the active ingredients in Microcyn.|